Trials / Unknown
UnknownNCT00487526
Duodenal Jejunal Bypass for Type 2 Diabetes (DJBD)
Clinical Evaluation of the Effect of Duodenal Jejunal Bypass on Type Two Diabetes in Non Obese Adults
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Ferzli, George S., M.D. F.A.C.S. · Individual
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Study the effect of Duodenal jejunal bypass on human adults with type 2 diabetes.
Detailed description
Adults non obese ( BMI less than 34 ) will undergo duodenal jejunal bypass. The Outcome measures: Blood Sugar, Insulin,HbA1c, CCK,Gastrin, GIP1and 2, Ghrelin, Cholesterol, Triglycerides,FFA, C-Peptide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | duodenal jejunal bypass |
Timeline
- Start date
- 2007-06-01
- First posted
- 2007-06-18
- Last updated
- 2007-07-11
Locations
1 site across 1 country: Dominican Republic
Source: ClinicalTrials.gov record NCT00487526. Inclusion in this directory is not an endorsement.